Ohm Laboratories, a subsidiary of an India-based manufacturer of generic medicine, announced today it is closing its Gloversville facility by October.
Ohm has 15 employees at the West Fulton Street plant, which the company has operated since 2002.
Ohm Vice President Charles M. Caprariello said operations now conducted in Gloversville will be outsourced as the company consolidates manufacturing at its two larger facilities in North Brunswick, N.J.
Caprariello said the Gloversville plant manufactures liquid ingredients for eight products. He said the company's primary business lies in the manufacturing of pills.
Though a company news release issued today cites strategic reasons for the closure, Caprariello said the slow economic recovery has led to a reduction in demand for the liquid products produced in Gloversville.
"It's not economically viable," he said of the Gloversville operation.
Caprariello said Ohm employs about 850 people in the United States and another 50 in Canada.
Ohm is a wholly-owned subsidiary of Ranbaxy Laboratories, India's largest pharmaceutical company.